End Hep C SF Data Dashboard - San Francisco's Hepatitis C Data
This scorecard shows San Francisco's progress toward eliminating Hepatitis C.
Why Is This Important?
HCV prevalence shows the number of people in San Francisco who have been exposed to HCV. This prevalence statistic is based on reactive antibody tests, meaning that it includes people who have active HCV infections, people who had HCV but cleared it on their own, and people who had HCV but cleared it through treatment. A downward trend in this curve is desirable because it means fewer people in San Francisco are living with HCV over time and shows us if the city's efforts are effective at reducing HCV. This estimate also serves as a baseline as we evaluate and measure the progress of our work going forward.
Why Is This Important?
Morbidity refers to the rate of disease in a population. A reduction in morbidity (illness) due to HCV would mean that fewer people in San Francisco are suffering from the impact of an HCV infection. Illnesses caused by HCV could include things such as cirrhosis and fibrosis of the liver as well as liver cancer.
Why Is This Important?
Mortality refers to deaths caused by HCV. A reduction in mortality would show us that San Francisco is making progress toward preventing new HCV infections and/or increasing access to treatment for HCV.
Clear Impact Suite is an easy-to-use, web-based software platform that helps your staff collaborate with external stakeholders and community partners by utilizing the combination of data collection, performance reporting, and program planning.